Sunday, December 1, 2024
wellness India Expo
Home Tags XALKORI

Tag: XALKORI

Pfizer’s LORBRENA achieves 60% five-year survival in ALK-positive lung cancer

Phase 3 CROWN trial shows 81% reduction in progression risk and 94% fewer brain metastases compared to XALKORI®